agtc-8k_20150908.htm

 

  

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 8, 2015

 

APPLIED GENETIC TECHNOLOGIES CORPORATION

(Exact name of Registrant as Specified in Its Charter)

 

 

Delaware

 

001-36370

 

59-3553710

(State or Other Jurisdiction

of Incorporation)

 

(Commission File Number)

 

(IRS Employer

Identification No.)

 

 

 

 

 

11801 Research Drive

Suite D

Alachua, Florida

 

 

 

32615

(Address of Principal Executive Offices)

 

 

 

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (386) 462-2204  

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 


 

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e)

On September 8, 2015, our board of directors approved bonus payments for fiscal year 2015 and salary increases for fiscal year 2016 for Sue Washer, our president and chief executive officer, Lawrence E. Bullock, our chief financial officer, and Jeffrey Chulay, our vice president and chief medical officer.  The following table sets forth for each individual the amount of their bonus for fiscal year 2015 and their salary for fiscal year 2016.

 

Name

Fiscal Year 2015 Bonus

Fiscal Year 2016 Salary

Susan B. Washer

$                                    90,000

$                                  464,000

Lawrence E. Bullock

$                                    76,500

$                                  327,000

Jeffrey D. Chulay

$                                    65,625

$                                  381,500

 

2

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

APPLIED GENETIC TECHNOLOGIES CORPORATION

 

 

 

Date:   September 11, 2015

 

By:

/s/ Lawrence E. Bullock

 

 

 

 

Lawrence E. Bullock

 

 

 

 

Chief Financial Officer

 

 

3